Insecticides India Ltd
Insecticides India Q3 FY25 earnings call: Revenue & Margins
Q3 FY25 earnings call: what management guided on revenue, margins and order book.
The short version
Targeting minimum 20% year-on-year growth in premium (B2C) products, particularly Maharatna segment. Targeting minimum 20% year-on-year growth in premium B2C segment volumes, especially focused on Maharatna products.
From Insecticides India Ltd's Q3 FY25 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Targeting minimum 20% year-on-year growth in premium (B2C) products, particularly Maharatna segment.
- Vision to increase premium product contribution to 65% of B2C sales within 1-2 years.
- Overall B2C volume growth reported around 19% in recent 9 months; value growth about 12%.
- Continuous launch of new profitable products, with 6-10 product launches planned annually.
- Expanding distributor network by approximately 4-5% and enhancing retailer/farmer engagement via CRM and digital tools.
- Planned operationalization of a new automated plant by 2026 expected to generate INR 500 crores in volumes at 70% capacity.
2 more points from Insecticides India Ltd's call on revenue
Pro opens every point from 15K+ earnings calls
Profitability & Margins
See what Insecticides India Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Significant capex underway at Sotanala (Rajasthan) and Dahej plants.
- Sotanala plant: includes formulation and technical manufacturing; target to start production in 2026.
- Dahej plant formulation expected to start by mid-2025 season (around June).
- Total capex planned around INR 125 crores over next 2 years, majority to be spent in next fiscal year.
- Expansion includes setting up a DCS plant with formulation facilities for liquids and other products on 15 acres.
- Investment in IIL Biologicals with large land purchased for future growth in biological products.
2 more points from Insecticides India Ltd's call on capex
Pro opens every point from 15K+ earnings calls
Top-ranked in Fertilizers & Agrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Insecticides India Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- The transcript does not explicitly mention the current or expected order book or pending orders for Insecticides India Limited.
- However, there is discussion on significant growth plans, including:
- Targeting 20% year-on-year growth in the premium B2C segment.
- Launching at least 6 new products in the next fiscal year.
- Setting up a new automated plant in Rajasthan expected to start operations in 2026, which will enhance production capacity.
- Expansion in biological products expected to contribute significantly over the medium term.
2 more points from Insecticides India Ltd's call on order book
Pro opens every point from 15K+ earnings calls
Insecticides India Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹385 Cr, net profit ₹10 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Insecticides India Ltd's management said in earlier quarters
Others in Fertilizers & Agrochemicals this season
- Sumitomo Chemical India Ltd (Q3 FY25)
641.9 crore, up 18% YoY from Rs. Key concall takeaways from Sumitomo Chemical India Ltd's Q3 FY25 earnings call — and how it ranks against sector peers.
- Punjab Chemicals & Crop Protection Ltd (Q3 FY25)
Capacity utilization for agrochemical division is at 72%, performance chemicals at 52%, with expansion plans underway, supporting growth (Page 3). Key concall…
- Paradeep Phosphates Ltd (Q3 FY25)
Q3 FY25 sales surged 47% YoY to 870,586 metric tons; 9 months sales up 13% YoY to 2.29 million tons. Key concall takeaways from Paradeep Phosphates Ltd's Q3…
- Dhanuka Agritech Ltd (Q3 FY25)
New registrations and marketing efforts are planned to revive and grow acquired Bayer products by 10-15% CAGR in subsequent years (Page 14). Key concall…
Arthneeti Pro · Annual
Insecticides India Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Insecticides India Ltd Q3 FY25 results?
Targeting minimum 20% year-on-year growth in premium (B2C) products, particularly Maharatna segment. Targeting minimum 20% year-on-year growth in premium B2C segment volumes, especially focused on Maharatna products.
What is Insecticides India Ltd share price analysis?
Insecticides India Ltd currently shows a neutral. The stock trades at a P/E of 14.7 with a market cap of ₹1,837 Cr. Investors should review the full earnings analysis for detailed insights.
Is Insecticides India Ltd planning capital expenditure?
Significant capex underway at Sotanala (Rajasthan) and Dahej plants.
Keep Insecticides India Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.